K
56
-4
COF
59
-4
SRE
63
-3
SO
53
-4
ADT
55
-3
KIM
70
-3
CINF
50
-3
AIG
44
-3
UNH
60
-3
ILMN
42
-3
GM
71
3
HSIC
42
-3
TDC
73
2
CTAS
56
-8
XRX
37
3
ADSK
70
-4
URBN
55
-11
GT
60
-2
HP
37
-8
NKE
31
-2
K
56
-4
COF
59
-4
SRE
63
-3
SO
53
-4
ADT
55
-3
KIM
70
-3
CINF
50
-3
AIG
44
-3
UNH
60
-3
ILMN
42
-3
GM
71
3
HSIC
42
-3
TDC
73
2
CTAS
56
-8
XRX
37
3
ADSK
70
-4
URBN
55
-11
GT
60
-2
HP
37
-8
NKE
31
-2
Financhill
Back

Vanguard Short-Term Corporate Bond ETF Vs. Dyne Therapeutics Industry Stock Comparison

Sell
40

VCSH
Vanguard Short-Term Corporate Bond ETF

Last Price:
78.08
Seasonality Move:
0.13%
Sell
46

DYN
Dyne Therapeutics

Last Price:
30.40
Seasonality Move:
38.02%
Sell
40
Vanguard Short-Term Corporate Bond ETF (VCSH) is a Sell

Is Vanguard Short-Term Corporate Bond ETF a Buy, Sell or Hold?

  • The current Vanguard Short-Term Corporate Bond ETF [VCSH] share price is $78.09. The Score for VCSH is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • VCSH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Dyne Therapeutics (DYN) is a Sell

Is Dyne Therapeutics a Buy, Sell or Hold?

  • The current Dyne Therapeutics [DYN] share price is $30.31. The Score for DYN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • DYN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VCSH Stock Price Chart

What is Vanguard Short-Term Corporate Bond ETF's stock price today?

  • The Vanguard Short-Term Corporate Bond ETF share price today is $78.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VCSH is experiencing selling pressure, which indicates risk of future bearish movement.

DYN Stock Price Chart

What is Dyne Therapeutics's stock price today?

  • The Dyne Therapeutics share price today is $30.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.

VCSH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 36.32 Sell
Chaikin Money Flow: -1623251 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (78.22 - 78.74) Sell
Bollinger Bands (100): (77.85 - 79.11) Sell

DYN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.91 Sell
Relative Strength Index (14 RSI): 47.11 Sell
Chaikin Money Flow: -1019710 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.92 - 33.44) Sell
Bollinger Bands (100): (31.39 - 42.57) Sell

VCSH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 78.23 Sell
20-day SMA: 78.39 Sell
50-day SMA: 78.84 Sell
200-day SMA: 77.74 Buy
8-day EMA: 78.22 Sell
20-day EMA: 78.39 Sell
50-day EMA: 78.56 Sell
200-day EMA: 77.86 Buy

DYN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 29.77 Buy
20-day SMA: 30.55 Sell
50-day SMA: 32.55 Sell
200-day SMA: 32.11 Sell
8-day EMA: 30.26 Buy
20-day EMA: 30.69 Sell
50-day EMA: 32.85 Sell
200-day EMA: 30.82 Sell

Vanguard Short-Term Corporate Bond ETF Earnings Growth & VCSH Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Dyne Therapeutics Earnings Growth & DYN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.10 per share.

Vanguard Short-Term Corporate Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Dyne Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):